Buford, GA, United States ,April 2026 — Senores Pharmaceuticals Limited has welcomed Chitrang Parikh as Vice President – Portfolio and Business Development, marking an important leadership addition for the company as it continues to expand its research-driven pharmaceutical business across regulated and emerging markets. With extensive experience across portfolio management, project management, analytical R&D, and pharmaceutical business leadership, he brings a strong and well-rounded profile to his new role.
Before joining Senores Pharmaceuticals, Chitrang Parikh served as Senior Director, Portfolio & Project Management at Rising Pharmaceuticals. Prior to that, he was associated with ASCENT PHARMACEUTICALS, INC. as Vice President, Portfolio and Project Management. These roles reflect a strong progression across portfolio leadership, project execution, and strategic pharmaceutical management.
A significant phase of his career was built at Amneal Pharmaceuticals, where he spent nearly two decades across multiple roles including Sr. Director, Project Management, Director, Project Management, Associate Director, Portfolio Management, and Associate Director, Analytical R&D. He was also associated with Amneal Pharmaceuticals of NY LLC in Analytical R&D leadership. This long tenure highlights a deep and sustained journey across product development, portfolio strategy, project management, and research leadership within the pharmaceutical industry.
With experience spanning Senores Pharmaceuticals, Rising Pharmaceuticals, ASCENT PHARMACEUTICALS, INC., Amneal Pharmaceuticals, and Amneal Pharmaceuticals of NY LLC, Chitrang Parikh brings strong domain expertise and leadership depth to his new role. His appointment as Vice President – Portfolio and Business Development is expected to support Senores Pharmaceuticals Limited as it continues to develop niche, complex, and specialty pharmaceutical products for global markets.
About Senores Pharmaceuticals Limited
Senores Pharmaceuticals is a global research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the US, Canada, and other regulated and emerging markets across various therapeutic areas and dosage forms. The company is committed to innovating and manufacturing products of high international quality standards and is focused on developing niche, complex, and specialty pharmaceutical products to support the global affordable healthcare ecosystem.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
